Business Wire

Planview Showcases Professional Services Automation Solutions at Technology & Services World 2021

Share

Planview, a global leader in Portfolio Management and Work Management solutions, today announced the company will be showcasing its Professional Services Automation (PSA) solutions at Technology & Services World (TSW) 2021, hosted by the Technology & Services Industry Association (TSIA) from October 18-20, 2021 in Las Vegas. Further extending the company’s expertise and leadership in PSA, the company also announced that Louise K. Allen, Chief Product Officer of Planview and PSA industry veteran, was recently named to TSIA’s Partner Advisory Board.

“Companies of all sizes and across industries are grappling with changing market and company dynamics,” said Allen. “At Planview, we've brought together the industry’s best PSA solutions under one roof to help our customers embrace those changes and achieve their outcomes. Planview Clarizen and Planview Changepoint, paired with our full portfolio of solutions and capabilities in PSA, PPM, Agile Services Delivery, and beyond, ensure that we can help organizations connect their businesses from idea to impact, and from opportunity to revenue.”

Building on the Professional Services Automation (PSA) pedigrees and industry leadership from the Clarizen and Changepoint acquisitions in early 2021, Planview’s PSA solutions enable organizations to accelerate services success – from delivery confidence to financial growth. Whether embedded, managed, or stand-alone professional services, Planview’s PSA solutions support customers from opportunity management, to delivery, to financial transparency. The company will showcase these solutions onsite at TSW 2021.

Additionally, Planview customer Leo Lovely, Sr. Director Professional Services at Vocera, will be presenting at TSW 2021 at 10:15am local time on Tuesday, October 19 in a session titled: “Unified Professional Services Platform Supports Vocera Growth Before and After Covid”. Focused on sharing how the Vocera team unified their professional services platform with Planview, the session will highlight how Vocera was able to quickly pivot to remote delivery at the beginning of the pandemic, and how the company continues to lead a seamless transition to the post-Covid world of work.

Planview’s attendance at TSW 2021 comes on the heels of Planview’s largest customer event in company history, Planview Accelerate, featuring PSA customer stories from across a range of industries, including: Bell Integration, IBM Cloud & Cognitive Services, Kensium, Tufin, Tyler Technologies, Siemens Energy, Wolters Kluwer, and more.

To learn more, please visit the Planview booth at TSW 2021 at the Aria Resort & Casino, or visit www.planview.info/TSW for more information.

About Planview

Planview has one mission: to build the future of connected work. Our solutions enable organizations to connect the business from ideas to impact, empowering companies to accelerate the achievement of what matters most. Planview’s full spectrum of Portfolio Management and Work Management solutions create organizational focus on the strategic outcomes that matter and empower teams to deliver their best work, no matter how they work. The comprehensive Planview platform and enterprise success model enable customers to deliver innovative, competitive products, services, and customer experiences. Headquartered in Austin, Texas with locations around the world, Planview has more than 1,000 employees supporting 4,000 customers and 2.4 million users worldwide. For more information, visit: www.planview.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Leslie Marcotte
lmarcotte@planview.com

About Business Wire

Business Wire
Business Wire
24 Martin Lane
EC4R 0DR London

+44 20 7626 1982http://www.businesswire.co.uk

(c) 2018 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

IPS acquires Linesight and partners for strategic growth18.10.2021 16:00:00 CEST | Press release

IPS-Integrated Project Services, LLC, headquartered in Blue Bell, Pennsylvania and a subsidiary of Alleghany Capital Corporation, today announced that it has acquired Linesight, a multinational consulting firm headquartered in Dublin, Ireland. IPS is a large EPCMV (Engineering, Procurement, Construction Management and Validation) company with over 1,700 staff across 22 offices worldwide. Linesight is a fast-growing professional consultancy services organization providing project controls to data center providers, life sciences companies, commercial real estate, healthcare, hospitality, retail and residential sectors. Linesight has over 900 staff across 24 offices globally. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211018005645/en/ The acquisition is being approached as a future integrated partnership where IPS will leverage Linesight’s experience and expertise in particular in the data center sector and Linesight in tur

Attensi og Eggs design vant innovasjonskontrakt med St. Olav. Skal lage neste generasjons trening for helsearbeidere og studenter innen psykisk helse18.10.2021 15:53:00 CEST | Pressemelding

Gode ferdigheter i å «lese», tolke og håndtere ulike møter med personer med psykiske lidelser tar tid å utvikle. For studenter og ansatte i fagfeltet psykisk helse er det utfordrende å få gjennomført tilstrekkelig mengdetrening i tillegg til møter med ekte pasienter. I løpet av de neste 12 månedene vil rundt 20 prosent av befolkningen i Norge ha utviklet en psykisk lidelse (kilde FHI), og riktig vurdering og håndtering er kritisk for en god bedringsprosess. Derfor skal neste generasjons opplæringsløsning nå utvikles, der helsepersonell gjennom bruk av spillelementer og avatarer skal få reell mengdetrening i å observere og videreformidle observasjoner om psykiske utfordringer. Krevende å vurdere riktig Det er et stort antall helsepersonell som er involvert i utredning, diagnostikk og behandling av personer med psykiske lidelser, og det kan være en krevende oppgave. Studenter innenfor helsefag oppgir ofte praksis knyttet til fagområdet psykisk helse som noe de opplever som spesielt kreve

Sumitomo SHI FW (SFW) Add CADMATIC Solutions to Further Support Digitalization, Data-driven Engineering, and Project Management18.10.2021 15:29:00 CEST | Press release

SFW is a provider of power, energy storage and environmental technologies and services for the global energy industry and has now entered into an agreement with CADMATIC Ltd to implement CADMATIC 3D plant design and information management solutions in their engineering projects in Finland, Poland, India, and China. The goal of the investment is to shorten lead times in design, engineering, and construction, improve the quality of design, and harmonize working methods across its international office network and subcontractors. The design and construction of a power plant is an extremely complex process that requires the integration of multiple design, engineering and construction disciplines, and many suppliers. CADMATIC software is an important element to streamline the process from design and engineering to construction and production and seamlessly integrate multiple parties in one project. Technical advantages in 3D Design, work-sharing, information management, and visualization wer

Deel Raises $425M in Series D Funding to Continue Transforming the Future of Work18.10.2021 14:45:00 CEST | Press release

Deel, the remote hiring company shattering job barriers worldwide, announced today that it has raised $425 million in Series D funding, taking the total amount raised by the company to over $630 million. The latest funding round values the company at $5.5 billion. Deel has become the highest valued company in the global hiring, payments, and compliance space with this investment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211018005567/en/ Deel Interface (Graphic: Business Wire) This new funding round was led by US-based Coatue, with partners Rahul Kishore and Lucas Swisher leading the deal. Several new and existing investors also participated in this round, including Altimeter Capital, Andreessen Horowitz, the YC Continuity Fund, Spark Capital, Greenbay Ventures, Neo, and over 40 of the world’s leading operators. Since Deel’s inception in 2019, the team - growing from four to 400 employees - has been on a mission to make

William Shatner Launches Everbridge’s ‘Unlocking Resilience’ Global Leadership Podcast Series, Available Today18.10.2021 14:30:00 CEST | Press release

Everbridge, Inc. (NASDAQ: EVBG) today announced the launch of its podcast Unlocking Resilience™: Global Leadership Seriesfeaturing William Shatner as its inaugural guest. The first-of-its-kind podcast features global influencers, government leaders, C-level executives and top healthcare experts as they discuss the confluence of leadership, technology and resilience at both the personal and organizational level. Topics will include overcoming personal challenges to create a life of resilience; effective strategies for building organizational resilience and business continuity in the face of critical events; and perspectives on the future of work, life and entertainment in a post-pandemic world, among other topics. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211018005565/en/ William Shatner Launches Everbridge’s ‘Unlocking Resilience’ Global Leadership Podcast Series, Available Today (Graphic: Business Wire) The Unlocking R

Ferring to Present Award-Winning, Real-World Outcomes Analysis for Investigational Microbiota-Based Live Biotherapeutic RBX2660 in Patients with Recurrent C. Difficile Infection and IBD at ACG 202118.10.2021 14:00:00 CEST | Press release

Ferring Pharmaceuticals and Rebiotix, a Ferring Company, today announced they will present data from two new retrospective analyses as part of American College of Gastroenterology’s Annual Scientific Meeting & Postgraduate Course (ACG 2021). The congress will take place in Las Vegas from October 22 – 27, 2021. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211018005060/en/ Eligibility criteria in CDI clinical trials often are narrowly defined, excluding broader patient populations. The first presentation will explore key health outcomes of RBX2660, an investigational microbiota-based live biotherapeutic for reduction of recurrent C. difficile infection (CDI), among patients in a real-world setting. The second analysis evaluates healthcare resource utilization and medical costs among Medicare patients with CDI with or without inflammatory bowel disease (IBD) as a comorbidity. Notably, one of the presentations has received The

Vertex Announces Positive Day 90 Data for the First Patient in the Phase 1/2 Clinical Trial Dosed With VX-880, a Novel Investigational Stem Cell-Derived Therapy for the Treatment of Type 1 Diabetes18.10.2021 13:30:00 CEST | Press release

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced positive Day 90 data for the first patient from the Phase 1/2 clinical trial of VX-880, an investigational stem cell-derived, fully differentiated pancreatic islet cell replacement therapy for people with type 1 diabetes (T1D). This is the first demonstration of a patient with T1D achieving robust restoration of islet cell function from such a cell therapy. The patient was treated with a single infusion of VX-880 at half the target dose in conjunction with immunosuppressive therapy. The patient achieved successful engraftment and demonstrated rapid and robust improvements in multiple measures, including increases in fasting and stimulated C-peptide, improvements in glycemic control, including HbA1c, and decreases in exogenous insulin requirement. VX-880 was generally well tolerated. “These results from the first patient treated with VX-880 are unprecedented. What makes these results truly remarkable is that they were ac